+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide Antibiotics Market - Global Forecast 2026-2032- Product Image
Peptide Antibiotics Market - Global Forecast 2026-2032- Product Image
New

Peptide Antibiotics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666281
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The peptide antibiotics market is experiencing renewed interest from healthcare, veterinary, and industrial sectors due to their unique ability to address antimicrobial resistance and meet evolving care protocols.

Market Snapshot

The peptide antibiotics market expanded from USD 532.67 million in 2025 to USD 576.96 million in 2026 and is poised for further growth at a CAGR of 9.28%, potentially achieving USD 991.61 million by 2032. This upwards trend reflects a combination of scientific innovation, clinical demand, and shifting procurement strategies across global healthcare and veterinary landscapes. Senior decision-makers are reviewing these dynamics as they reallocate investments and consider competitive positioning.

Scope & Segmentation

This report delivers a comprehensive view of the peptide antibiotics market, emphasizing both molecular innovation and practical delivery challenges. Analysis covers the following key segments and industry dimensions:

  • Product Types: Bacitracin, colistin, daptomycin, polymyxin B, along with legacy and next-generation analogs.
  • Formulation Variants: Lyophilized injectables, topical creams, ointments, and oral route formulations tailored to diverse care environments.
  • Route of Administration: Intravenous, intramuscular, topical, and oral, each mapped to unique clinical and veterinary use cases.
  • Source Characteristics: Distinction between natural and synthetic peptides affecting manufacturing complexity and intellectual property dynamics.
  • Applications: Clinical treatment, veterinary medicine, and select industrial uses such as food preservation.
  • End-Use Environments: Hospitals, clinics, veterinary practices, and outpatient care settings.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy, each with tailored support requirements.
  • Geographies: Americas, Europe/Middle East/Africa (EMEA), Asia-Pacific, with attention to regulatory and supply chain distinctions.
  • Technology Advances: Developments in peptide synthesis, sequence engineering for improved spectrum and stability, and manufacturing scalability.

Key Takeaways

  • Peptide antibiotics are regaining momentum as valuable tools in antimicrobial stewardship, with both established molecules and engineered analogs supporting evolving treatment protocols.
  • Formulation advances now enable wider adoption, with innovations targeting improved stability and various routes of administration—reducing historic constraints linked to degradation and patient compliance.
  • Stakeholder adoption decisions are increasingly shaped by stewardship requirements, evidence-driven outcomes, and performance in procurement processes across human and veterinary applications.
  • Supply chain strategies are being restructured with more focus on resilience, diversification, and transparency due to recent policy changes and trade risks.
  • Regional dynamics strongly affect market access: Americas focus on data-driven formulary engagement; EMEA balance regulatory harmonization with localized requirements; Asia-Pacific leverages its manufacturing base to deliver tailored solutions.
  • Competitive advantage is moving toward organizations that couple scientific differentiation with strong channel management, regulatory relationships, and adaptive manufacturing partnerships.

Tariff Impact

Recent United States tariff measures enacted in 2025 have heightened supply chain complexity, pushing both procurement and manufacturing leaders to diversify sourcing strategies and secure longer-term agreements. These policies prompted nearshoring evaluations and influenced the prioritization of product lines, requiring manufacturers and buyers to balance cost pass-through mechanisms, logistics, and compliance while keeping R&D and capacity expansion on track. Regulatory and payer oversight grew, urging greater transparency in sourcing to guarantee patient and veterinary access.

Methodology & Data Sources

This research utilized a mixed-methods approach, combining primary stakeholder interviews with clinicians, procurement leaders, veterinary practitioners, and manufacturing executives. Supplementary analysis included systematic reviews of scientific and regulatory literature, clinical trial databases, and patent filings. Supply chain mapping and scenario analysis provided additional layers of operational context, while internal quality controls and ethical compliance ensured rigor and confidentiality.

Why This Report Matters

  • Access actionable guidance for developing resilient formulation, procurement, and commercialization strategies aligned with emerging clinical and regulatory demands.
  • Learn how competitive dynamics and regional policies influence go-to-market opportunities, manufacturing partnerships, and stewardship compliance.
  • Apply robust segmentation insights to differentiate product and channel offerings that support sustained adoption in target end-use environments.

Conclusion

Comprehensive analysis of the peptide antibiotics market equips senior leaders to navigate complexity, mitigate risks, and convert innovation into effective therapeutic solutions. Aligning scientific progress with adaptive market access and supply strategies ensures sustainable value in human and veterinary medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Peptide Antibiotics Market, by Product
8.1. Bacitracin
8.2. Colistin
8.3. Daptomycin
8.4. Polymyxin B
9. Peptide Antibiotics Market, by Route Of Administration
9.1. Intramuscular
9.2. Intravenous
9.3. Oral
9.4. Topical
10. Peptide Antibiotics Market, by Formulation
10.1. Injectable
10.1.1. Lyophilized Powder
10.1.2. Solution
10.2. Powder
10.3. Topical Formulation
10.3.1. Cream
10.3.2. Ointment
11. Peptide Antibiotics Market, by Source
11.1. Natural
11.2. Synthetic
12. Peptide Antibiotics Market, by Application
12.1. Clinical Use
12.2. Food Preservation
12.3. Veterinary Use
13. Peptide Antibiotics Market, by End Use
13.1. Clinics
13.2. Hospitals
13.3. Veterinary Clinics
14. Peptide Antibiotics Market, by Distribution Channel
14.1. Hospital Pharmacy
14.2. Online Pharmacy
14.3. Retail Pharmacy
15. Peptide Antibiotics Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Peptide Antibiotics Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Peptide Antibiotics Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Peptide Antibiotics Market
19. China Peptide Antibiotics Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. AbbVie Inc.
20.6. AMP Biotech, Inc.
20.7. ANI Pharmaceuticals, Inc.
20.8. AstraZeneca plc
20.9. Bachem Holding AG
20.10. ContraFect Corporation
20.11. CordenPharma International GmbH
20.12. Cumberland Pharmaceuticals Inc.
20.13. Eli Lilly and Company
20.14. GlaxoSmithKline plc
20.15. Lytix Biopharma AS
20.16. Melinta Therapeutics, LLC
20.17. Merck & Co., Inc.
20.18. Nabriva Therapeutics plc
20.19. Neuland Laboratories Limited
20.20. Novabiotics Ltd.
20.21. Novartis AG
20.22. Peptilogics, Inc.
20.23. Pfizer Inc.
20.24. Phoenix Biotechnology, Inc.
20.25. PolyPeptide Group AB
20.26. Sanofi S.A.
20.27. Teva Pharmaceutical Industries Ltd.
20.28. Thermo Fisher Scientific Inc.
20.29. Xellia ApS
List of Figures
FIGURE 1. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PEPTIDE ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 132. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 152. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 153. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 154. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 155. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 156. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 175. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 180. ASEAN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 183. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 185. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 186. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 187. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 188. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 190. GCC PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 203. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 205. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 206. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 207. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 208. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 210. BRICS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 213. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 214. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 215. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 216. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 217. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 218. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 220. G7 PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 223. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 224. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 225. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 226. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 227. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 228. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 230. NATO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 244. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 245. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 246. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 247. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2032 (USD MILLION)
TABLE 248. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 249. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 251. CHINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Peptide Antibiotics market report include:
  • AbbVie Inc.
  • AMP Biotech, Inc.
  • ANI Pharmaceuticals, Inc.
  • AstraZeneca plc
  • Bachem Holding AG
  • ContraFect Corporation
  • CordenPharma International GmbH
  • Cumberland Pharmaceuticals Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Lytix Biopharma AS
  • Melinta Therapeutics, LLC
  • Merck & Co., Inc.
  • Nabriva Therapeutics plc
  • Neuland Laboratories Limited
  • Novabiotics Ltd.
  • Novartis AG
  • Peptilogics, Inc.
  • Pfizer Inc.
  • Phoenix Biotechnology, Inc.
  • PolyPeptide Group AB
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Xellia ApS

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 576.96 Million
Forecasted Market Value ( USD ) by 2032 $ 991.61 Million
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Peptide Antibiotics Market Report 2025 - Product Image

Peptide Antibiotics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Peptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Peptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Peptide Antibiotics - Global Strategic Business Report - Product Image

Peptide Antibiotics - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From

About the Peptide Antibiotics Market

Peptide antibiotics are a type of antibiotic derived from peptides, which are short chains of amino acids. They are used to treat a variety of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria. Peptide antibiotics are generally more effective than traditional antibiotics, as they are able to target specific bacterial cells and are less likely to cause resistance. They are also less likely to cause side effects, such as nausea and vomiting. Peptide antibiotics are typically administered intravenously or intramuscularly, and can be used in combination with other antibiotics. The peptide antibiotics market is growing rapidly, driven by the increasing prevalence of antibiotic-resistant bacteria and the need for more effective treatments. The market is expected to continue to grow in the coming years, as more research is conducted into the development of new peptide antibiotics. Some companies in the peptide antibiotics market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.